Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline and up to 600 characters of the feed's description, not by an editor, and are not checked against the text. They are neutral and information-only, Kresmion publishes no buy or sell recommendations. New SEC filings, and Bank of England and Bank of Japan items, carry no note.
Public RSS feeds · refreshed every 30 minutes
8814 items · filings · clear filters
- 8-K - INGLES MARKETS INC (0000050493) (Filer)
Automated noteIngles Markets Inc. filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition, providing a Regulation FD disclosure, and attaching its financial statements and related exhibits.
- 8-K - ITT INC. (0000216228) (Filer)
Automated noteITT Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing its financial statements and related exhibits.
- 8-K - LEXICON PHARMACEUTICALS, INC. (0001062822) (Filer)
Automated noteLexicon Pharmaceuticals filed a Form 8-K on August 6, 2026, including Item 2.02 covering results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - MACOM Technology Solutions Holdings, Inc. (0001493594) (Filer)
Automated noteMACOM Technology Solutions Holdings, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and related exhibits (Item 9.01).
- 8-K - COLLEGIUM PHARMACEUTICAL, INC (0001267565) (Filer)
Automated noteColleium Pharmaceutical, Inc. filed a Form 8-K on August 6, 2026. The filing includes Item 2.02 reporting results of operations and financial condition, and Item 7.01 containing a Regulation FD disclosure.
- 8-K - Cronos Group Inc. (0001656472) (Filer)
Automated noteCronos Group Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 (results of operations and financial condition) and Item 9.01 (financial statements and exhibits).
- 8-K - Optimum Communications, Inc. (0001702780) (Filer)
Automated noteOptimum Communications, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Cheniere Energy Partners, L.P. (0001383650) (Filer)
Automated noteCheniere Energy Partners, L.P. filed a Form 8-K on August 6, 2026, disclosing its results of operations and financial condition for the period and attaching the related financial statements and exhibits.
- 8-K - Installed Building Products, Inc. (0001580905) (Filer)
Automated noteInstalled Building Products, Inc. filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition (Item 2.02), a Regulation FD disclosure (Item 7.01), and accompanying financial statements and exhibits (Item 9.01).
- 8-K - RE/MAX Holdings, Inc. (0001581091) (Filer)
Automated noteRE/MAX Holdings, Inc. filed a Form 8-K with the SEC on August 6, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001104659-26-091642, 304 KB).
- 8-K - Commerce.com, Inc. (0001626450) (Filer)
Automated noteCommerce.com, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - OPEN TEXT CORP (0001002638) (Filer)
Automated noteOpen Text Corp filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02), other events (Item 8.01), and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Zoetis Inc. (0001555280) (Filer)
Automated noteZoetis Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and related exhibits (Item 9.01).
- 8-K - Cullinan Therapeutics, Inc. (0001789972) (Filer)
Automated noteCullinan Therapeutics filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - Vistance Networks, Inc. (0001517228) (Filer)
Automated noteVistance Networks filed a Form 8-K reporting departures and appointments of officers and directors, related compensatory arrangements, other events, and accompanying financial statements and exhibits.
- 8-K - Smith Douglas Homes Corp. (0001982518) (Filer)
Automated noteSmith Douglas Homes Corp. filed a Form 8-K on August 6, 2026, including Item 2.02 detailing its results of operations and financial condition, and Item 9.01 providing its financial statements and related exhibits.
- 8-K - Shift4 Payments, Inc. (0001794669) (Filer)
Automated noteShift4 Payments, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - Core Natural Resources, Inc. (0001710366) (Filer)
Automated noteCore Natural Resources, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.
- 8-K - BENTLEY SYSTEMS INC (0001031308) (Filer)
Automated noteBentley Systems Inc. filed a Form 8-K on August 6, 2026, disclosing its results of operations and financial condition and attaching its financial statements and related exhibits.
- 8-K - Resolute Holdings Management, Inc. (0002039497) (Filer)
Automated noteResolute Holdings Management, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)
Automated noteIovance Biotherapeutics filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition (Item 2.02) and providing financial statements and exhibits (Item 9.01).
- 8-K - BlackSky Technology Inc. (0001753539) (Filer)
Automated noteBlackSky Technology Inc. filed a Form 8-K on August 6, 2026 (Accession No. 0001753539-26-000118), reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Tecnoglass Holdings Inc. (0001534675) (Filer)
Automated noteTecnoglass Holdings Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and exhibits (Item 9.01).
- 8-K - Vital Farms, Inc. (0001579733) (Filer)
Automated noteVital Farms, Inc. filed a Form 8-K reporting entry into and termination of material definitive agreements, disclosed its results of operations and financial condition, created a direct financial obligation/off-balance-sheet arrangement, and provided related financial statements and exhibits.
- 8-K - Viridian Therapeutics, Inc.\DE (0001590750) (Filer)
Automated noteViridian Therapeutics, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer)
Automated noteLigand Pharmaceuticals Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Opus Genetics, Inc. (0001228627) (Filer)
Automated noteOpus Genetics, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 covering its results of operations and financial condition and Item 9.01 containing its financial statements and exhibits.
- 8-K - Korro Bio, Inc. (0001703647) (Filer)
Automated noteKorro Bio, Inc. filed a Form 8-K reporting a material definitive agreement, its results of operations and financial condition, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - Warner Bros. Discovery, Inc. (0001437107) (Filer)
Automated noteWarner Bros. Discovery, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 (results of operations and financial condition), Item 7.01 (Regulation FD disclosure), and Item 9.01 (financial statements and exhibits).
- 8-K - Monte Rosa Therapeutics, Inc. (0001826457) (Filer)
Automated noteMonte Rosa Therapeutics, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 results of operations and financial condition and Item 9.01 financial statements and exhibits.